Scl-70 antibody

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Anti-Topoisomerase I antibody; Scl70-AK; Topoisomerase antibody

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

General informationThis section has been translated automatically.

Belong to the group of antibodies against "extractable nuclear antigens"(ENA). Scl-70 autoantibodies are directed against DNA topoisomerase I, a 100kD protein which is nucleoplasmically and nucleolarily localized. In indirect immunofluorescence, Scl-70 autoantibodies show a mostly diffuse granular distribution of the antigen in the cell nucleus. Scl-70 antibodies are detected in systemic lupus erythematosus (SLE) in 25-75% of cases.

They are also indicative of diffuse scleroderma (frequency up to 70%). As a rule, this autoantibody correlates with a more severe course and unfavourable prognosis. In patients with limited scleroderma, SCl-70-Ak is only detected in about 20% of cases. Furthermore, Scl-70 antibodies are found in overlap syndromes with other collagenoses.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer